首页> 外文OA文献 >Human chymotrypsinogen B production with Pichia pastoris by integrated development of fermentation and downstream processing. 1: Fermation processing
【2h】

Human chymotrypsinogen B production with Pichia pastoris by integrated development of fermentation and downstream processing. 1: Fermation processing

机译:通过发酵和下游加工的综合开发,利用巴斯德毕赤酵母生产人胰凝乳蛋白酶原B。 1:发酵处理

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Based on an integrated approach of genetic engineering, fermentation process development, and downstream processing, a fermentative chymotrypsinogen B production process using recombinant Pichia pastoris is presented. Making use of the P. pastoris AOX1-promotor, the demand for methanol as the single carbon source as well as an inducer of protein secretion enforced the use of an optimized feeding strategy by help of on-line analysis and an advanced controller algorithm. By using an experimental system of six parallel sparged column bioreactors, proteolytic product degradation could be minimized while also optimizing starting conditions for the following downstream processing. This optimization of process conditions resulted in the production of authentic chymotrypsinogen at a final concentration level of 480 mg.L(-)(1) in the whole broth and a biomass concentration of 150 g.L(-)(1) cell dry weight, thus comprising a space-time yield of 5.2 mg.L(-)(1).h(-)(1). Alternatively to the high cell density fermentation approach, a continuous fermentation process was developed to study the effects of reduced cell density toward oxygen demand, cooling energy, and biomass separation. This development led to a process with a highly increased space-time yield of 25 mg.L(-)(1).h(-)(1) while reducing the cell dry weight concentration from 150 g.L(-)(1) in fed-batch to 65 g.L(-)(1) in continuous cultivation.
机译:基于基因工程,发酵工艺开发和下游加工的综合方法,提出了使用重组巴斯德毕赤酵母的发酵性胰凝乳蛋白酶原B生产工艺。利用巴斯德毕赤酵母AOX1启动子,对甲醇作为单一碳源以及蛋白质分泌诱导剂的需求通过在线分析和高级控制器算法的帮助,强制采用了优化的饲喂策略。通过使用包含六个平行喷射塔式生物反应器的实验系统,可以最大程度地减少蛋白水解产物的降解,同时还可以优化后续下游处理的起始条件。工艺条件的这种优化导致了真正的胰凝乳蛋白酶原的产生,其最终浓度在整个肉汤中为480 mg.L(-)(1),生物质浓度为150 gL(-)(1)细胞干重,因此时空产率为5.2 mg.L(-)(1).h(-)(1)。除了高细胞密度发酵方法以外,还开发了一种连续发酵工艺来研究降低的细胞密度对氧气需求,冷却能和生物质分离的影响。这一发展导致了一个过程,该过程的时空产率大大提高了25 mg.L(-)(1).h(-)(1),同时将细胞干重浓度从150 gL(-)(1)降低了在连续培养中分批补料至65 gL(-)(1)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号